← Leaderboards
Mohit Jain
Brigham And Women'S Hospital
$6,712,308
Attributed
$7,457,229
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2011–24$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,457,229 · 8
By mechanism
R01$4,820,153 · 2
U54$964,976 · 2
K08$684,600 · 1
S10$600,000 · 1
R03$387,500 · 2
Top collaborators
- Sonia Sharma2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Susan Cheng$21,020,819
- David A. Hafler$48,350,086
- Vesela Kovacheva$1,048,302
- Jonathan Peter Arm$4,161,735
- Sushila Maharjan$246,125
Others in their field
Top investigators on “Mass Spectrum Analysis”
- Paul S. Aisen · Cognition Therapeutics, Inc.$30,310,037
- Reisa A. Sperling · Banner Health$30,310,037
- Richard D Smith · Battelle Pacific Northwest Laboratories$28,842,237
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$28,666,849
- David Heimbrook · Leidos Biomedical Research, Inc.$27,692,696
- John Robert Yates · Scripps Research Institute, The$26,948,886
Research focus
Mass Spectrum AnalysisResearch PersonnelInsightScientistSamplingBiologicalMolecularFoundationsBaseLiquid Chromatography Mass SpectrometryPlasmaTrainingCohortCardiovascular DiseasesFundingLongevityPhysiologyProspectiveResponseHeart FailureNovel StrategiesOrganCareerInnovation
Grant awards (23)
MAE-WEST RSC - Eicosanoids Profiling Core$154,818
U54 · FY2024 · AG · contact PI
MAE-WEST RSC - Eicosanoids Profiling Core$153,760
U54 · FY2023 · AG · contact PI
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy$706,425
R01 · FY2022 · CA
MAE-WEST RSC - Eicosanoids Profiling Core$248,755
U54 · FY2022 · AG · contact PI
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy$783,417
R01 · FY2021 · CA
Mapping the Plasma Exposome and its Association with Human Cardiovascular Disease$581,433
R01 · FY2021 · ES · contact PI
MAE-WEST RSC - Eicosanoids Profiling Core$249,001
U54 · FY2021 · AG · contact PI
Mapping the Plasma Exposome and its Association with Human Cardiovascular Disease$586,689
R01 · FY2020 · ES · contact PI
MAE-WEST RSC - Eicosanoids Profiling Core$158,642
U54 · FY2020 · AG · contact PI
Mapping the Plasma Exposome and its Association with Human Cardiovascular Disease$594,439
R01 · FY2019 · ES · contact PI
Mapping the Plasma Exposome and its Association with Human Cardiovascular Disease$597,920
R01 · FY2018 · ES · contact PI
Mapping the Plasma Exposome and its Association with Human Cardiovascular Disease$392,500
R01 · FY2018 · ES · contact PI
Mapping the Plasma Exposome and its Association with Human Cardiovascular Disease$577,330
R01 · FY2017 · ES · contact PI
Reactive electrophiles in human aging and longevity$116,250
R03 · FY2017 · AG · contact PI
Mapping metabolic activities in stem cell-derived models of human cardiomyopathy$77,500
R03 · FY2017 · HL · contact PI
Reactive electrophiles in human aging and longevity$116,250
R03 · FY2016 · AG · contact PI
Mapping metabolic activities in stem cell-derived models of human cardiomyopathy$77,500
R03 · FY2016 · HL · contact PI
RapidFire mass spectrometry system$600,000
S10 · FY2015 · OD · contact PI
A systems approach to metabolic dysregulation in the heart$136,920
K08 · FY2015 · HL · contact PI
A systems approach to metabolic dysregulation in the heart$136,920
K08 · FY2014 · HL · contact PI
A systems approach to metabolic dysregulation in the heart$136,920
K08 · FY2013 · HL · contact PI
A systems approach to metabolic dysregulation in the heart$136,920
K08 · FY2012 · HL · contact PI
A systems approach to metabolic dysregulation in the heart$136,920
K08 · FY2011 · HL · contact PI